Publications by authors named "Zhao Xujie"

Medical image translation is of great value but is very difficult due to the requirement with style change of noise pattern and anatomy invariance of image content. Various deep learning methods like the mainstream GAN, Transformer and Diffusion models have been developed to learn the multi-modal mapping to obtain the translated images, but the results from the generator are still far from being perfect for medical images. In this paper, we propose a robust multi-contrast translation framework for MRI medical images with knowledge distillation and adversarial attack, which can be integrated with any generator.

View Article and Find Full Text PDF

Antimicrobial peptides (AMPs) possess vaccine adjuvant activity; however, their specific targets and molecular mechanisms remain incompletely understood, which hinders their clinical application. This study aimed to elucidate the key targets and pathways through which the antimicrobial peptide BSN-37 modulates immune responses in macrophages, providing evidence for its potential clinical translation. In this investigation, Balb/c mice were administered BSN-37 for 12 h, after which total RNA was extracted from peritoneal macrophages to assess the mRNA expression levels of cytokines and key molecules on the cell surface, followed by transcriptomic sequencing.

View Article and Find Full Text PDF

Objective: To explore the prevalence and influencing factors of Chronic Kidney Disease-associated Pruritus (CKD-aP) among maintenance hemodialysis (MHD) patients in China through a meta-analysis.

Methods: A systematic computerized search was conducted across ten databases, including CNKI, VIP, Wanfang, PubMed, Web of Science, and The Cochrane Library, to identify studies on the prevalence and influencing factors of pruritus among Chinese hemodialysis patients up to January 2025. Two independent graduate students conducted literature screening, data extraction, and bias risk assessment for the included studies.

View Article and Find Full Text PDF

Background: This is a scoping review of the evidence for the use of the Patient Self-Management Assessment Tool for Hypertension (PAT) in people with hypertension. This review examines the content features, reliability, and validity of the PAT for people with Hypertension, as well as contextual and environmental evidence for the tool implementation in clinical practice.

Objective: To synthesize and evaluate the self-management assessment tools available for people with hypertensive, and to guide healthcare professionals in selecting appropriate tools.

View Article and Find Full Text PDF

Background: The programmed cell death 1 (PD-1) is an immune checkpoint that mediates immune evasion of tumors. Alternative splicing (AS) such as intron retention (IR) plays a crucial role in the immune-related gene processing and its function. However, it is not clear whether encoding PD-1 exists as an IR splicing isoform and what underlying function of such isoform plays in tumor evasion.

View Article and Find Full Text PDF

Heterogeneous roles of complement C3 have been implicated in tumor metastasis and are highly context dependent. However, the underlying mechanisms linking C3 to tumor metastasis remain elusive in renal cell carcinoma (RCC). Here, we demonstrate that C3 of RCC cell-derived extracellular vesicles (EVs) contributes to metastasis via polarizing tumor-associated macrophages (TAMs) into the immunosuppressive phenotype and recruiting polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs).

View Article and Find Full Text PDF

The function of PD-1/PD-L1 axis have been intensively studied for immune escape of various cancers. However, the underlying function of PD-L2 remains poorly understood. Here, we demonstrate that PD-L2 is majorly expressed in exosomes with surface localization by clear cell renal cell carcinoma (ccRCC) cells.

View Article and Find Full Text PDF

The triglyceride-glucose (TyG) index, a reliable surrogate biomarker of insulin resistance (IR), is highlighted recently as related to cardiac disorders. However, the associations of the TyG index and its combination with blood pressure (BP) on cardiovascular and all-cause mortality in hypertension remain unclear. In this study, we included 9,635 hypertension patients from the National Health and Nutrition Examination Survey 1999-2018.

View Article and Find Full Text PDF

The immune checkpoint receptor, programmed cell death 1 (PD-1, encoded by PDCD1), mediates the immune escape of cancer, but whether PD-1 splicing isoforms contribute to this process is still unclear. Here, we identify an alternative splicing isoform of human PD-1, which carries a 28-base pairs extension retained from 5' region of intron 2 (PD-1^28), is expressed in peripheral T cells and tumor infiltrating lymphocytes. PD-1^28 expression is induced on T cells upon activation and is regulated by an RNA binding protein, TAF15.

View Article and Find Full Text PDF

TGF-β-SMAD signaling pathway plays an important role in the progression of various cancers. However, posttranscriptional regulation such as N-methyladenosine (mA) of TGF-β-SMAD signaling axis remains incompletely understood. Here, we reveal that insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) is low expression as well as associated with poor prognosis in clear cell renal cell carcinoma (ccRCC) patients and inhibits proliferation as well as promotes metastasis of ccRCC cells.

View Article and Find Full Text PDF

Effectively targeting transcription factors in therapeutic interventions remains challenging, especially in core-binding factor-acute myeloid leukaemia (CBF-AML) characterized by RUNX1::ETO and CBFβ::MYH11 fusions. However, recent studies have drawn attention towards aberrant amino acid metabolisms as actionable therapeutic targets. Here, by integrating the expression profile and genetic makeup in AML cohort, we found higher BCAT1 expression in CBF-AML patients compared with other subtypes.

View Article and Find Full Text PDF

Accumulating evidence indicates that HOXA9 dysregulation is necessary and sufficient for leukemic transformation and maintenance. However, it remains largely unknown how HOXA9, as a homeobox transcriptional factor, binds to noncoding regulatory sequences and controls the downstream genes. Here, we conduct dropout CRISPR screens against 229 HOXA9-bound peaks identified by ChIP-seq.

View Article and Find Full Text PDF

Hypoxia is a common hallmark of cancer and plays a crucial role in promoting epithelial-mesenchymal transition (EMT). Hormonally Upregulated Neu-associated Kinase (HUNK) regulates EMT through its kinase activity. However, whether hypoxia is involved in HUNK-mediated EMT is incompletely understood.

View Article and Find Full Text PDF

ETS variant 6 (ETV6) encodes a transcriptional repressor expressed in hematopoietic stem and progenitor cells (HSPCs), where it is required for adult hematopoiesis. Heterozygous pathogenic germline ETV6 variants are associated with thrombocytopenia 5 (T5), a poorly understood genetic condition resulting in thrombocytopenia and predisposition to hematologic malignancies. To elucidate how germline ETV6 variants affect HSPCs and contribute to disease, we generated a mouse model harboring an Etv6R355X loss-of-function variant, equivalent to the T5-associated variant ETV6R359X.

View Article and Find Full Text PDF

Blinatumomab is an efficacious immunotherapeutic agent in B cell acute lymphoblastic leukemia (B-ALL). However, the pharmacogenomic basis of leukemia response to blinatumomab is unclear. Using genome-wide CRISPR, we comprehensively identified leukemia intrinsic factors of blinatumomab sensitivity, i.

View Article and Find Full Text PDF
Article Synopsis
  • FLT3 is a promising target for treating acute lymphoblastic leukemia (ALL), but how it's activated in this disease isn't fully understood.
  • Researchers found that ALL patients with ZNF384 gene rearrangements consistently over-express FLT3, linked to a specific enhancer element that activates FLT3 only in these cases.
  • Reducing ZNF384 levels decreases FLT3 activation and makes ALL cells less responsive to the FLT3 inhibitor gilteritinib, which has shown effective anti-leukemia effects in models of ZNF384-rearranged ALL.
View Article and Find Full Text PDF

There is growing evidence for an inherited basis of susceptibility to childhood acute lymphoblastic leukemia. Genomewide association studies by us and others have identified non-coding acute lymphoblastic leukemia risk variants at the ARID5B gene locus, but the molecular mechanisms linking ARID5B to normal and malignant hematopoiesis remain largely unknown. Using a Vav1-driven transgenic mouse model, we characterized the role of Arid5b in hematopoiesis in vivo.

View Article and Find Full Text PDF
Article Synopsis
  • There is a genetic link to childhood acute lymphoblastic leukemia (ALL), particularly involving non-coding variants at the ARID5B gene locus, which are linked to leukemia risk but have unclear functional effects.
  • Researchers analyzed the ARID5B gene in over 5,000 children with ALL and identified variants that could impact the gene's expression and susceptibility to leukemia, confirming their findings using advanced genomic techniques.
  • A highly significant risk variant (rs7090445) was found within an enhancer region that affects the binding of the transcription factor MEF2C, suggesting a crucial role for this mechanism in the development of ALL.
View Article and Find Full Text PDF

Nucleobase and nucleoside analogs (NNA) are widely used as anti-viral and anti-cancer agents, and NNA phosphorylation is essential for the activity of this class of drugs. Recently, diphosphatase NUDT15 was linked to thiopurine metabolism with NUDT15 polymorphism associated with drug toxicity in patients. Profiling NNA drugs, we identify acyclovir (ACV) and ganciclovir (GCV) as two new NNAs metabolized by NUDT15.

View Article and Find Full Text PDF

Genetic alterations in the RUNX1 gene are associated with benign and malignant blood disorders, particularly of megakaryocyte and myeloid lineages. The role of RUNX1 in acute lymphoblastic leukemia (ALL) is less clear, particularly how germline genetic variation influences the predisposition to this type of leukemia. Sequencing 4,836 children with B-ALL and 1,354 cases of T-ALL, we identified 31 and 18 germline RUNX1 variants, respectively.

View Article and Find Full Text PDF

Background: A phase 1 study was conducted to determine the maximum tolerated dose of bendamustine when given in combination with clofarabine, etoposide, and dexamethasone daily for 5 days in children and adolescents with relapsed or refractory hematologic malignancies.

Methods: Patients younger than 22 years with second or greater relapsed or refractory acute leukemia or lymphoma after 2 or more prior regimens were eligible. With the rolling 6 design, participants received escalating doses of bendamustine (30, 40, or 60 mg/m /d) in combination with clofarabine (40 mg/m ), etoposide (100 mg/m ), and dexamethasone (8 mg/m ) daily for 5 days.

View Article and Find Full Text PDF
Article Synopsis
  • Aberrant expression of the KMT2A (MLL) gene in aggressive acute leukemias is linked to poor outcomes and the maintenance of leukemia.
  • Researchers created knock-in reporter cell lines using CRISPR/Cas9 screens to identify transcription factors that regulate this gene, discovering that the novel regulator USF2 plays a crucial role.
  • Depleting USF2 reduced leukemia cell proliferation and affected gene expression, while introducing Hoxa9 could reverse this effect, highlighting the complexities of the molecular regulation in MLL-driven leukemias.
View Article and Find Full Text PDF

Background: Sodium tanshinone IIA sulfonate (STS) has been widely used by Chinese medicine practitioners for chronic cardiovascular diseases. However, its direct clinical efficacy in patients with acute coronary syndrome following percutaneous coronary intervention (PCI) has not been reported yet. The present trial aimed to investigate potential cardioprotection of STS in patients undergoing PCI for non-ST elevation acute coronary syndrome (NSTE-ACS).

View Article and Find Full Text PDF
Article Synopsis
  • There is increasing evidence that certain inherited genetic variations, specifically in the ETV6 gene, can increase the risk of childhood acute lymphoblastic leukemia (ALL) and create a new leukemia predisposition syndrome.
  • Researchers studied 32 childhood leukemia cases influenced by these ETV6 variants, finding 22 that disrupt critical functions of the ETV6 protein, which is important for regulating gene expression.
  • The study showed that ETV6 variants significantly alter the genetic landscape of ALL, with different leukemia cases displaying unique mutations and karyotypes, highlighting the complex relationship between genetic inheritance and acquired mutations in leukemia development.
View Article and Find Full Text PDF